Temat: "SIALIC-ACID" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: CD33 as a leukocyte-associated marker expressed on human spermatozoa.
Autorzy:: Sereshki N; Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Rafiee M; Department of Immunology, Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, 9717853577, Iran. .
Alipour R; Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Rahimyan K; Department of Microbiology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Wilkinson D; University of Aberdeen, Scotland, UK.; Pokaż więcej
Źródło:: BMC research notes [BMC Res Notes] 2023 Apr 20; Vol. 16 (1), pp. 57. Date of Electronic Publication: 2023 Apr 20.
Typ publikacji:: Journal Article
MeSH Terms:: Antigens, CD*
Sialic Acid Binding Immunoglobulin-like Lectins*/metabolism
Male ; Humans ; Antigens, Differentiation, Myelomonocytic ; Leukocytes/metabolism ; Spermatozoa ; Sialic Acid Binding Ig-like Lectin 3

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: The role of sialic acid-binding immunoglobulin-like-lectin-1 (siglec-1) in immunology and infectious disease.
Autorzy:: Prenzler S; School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Queensland, Australia.; Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Rudrawar S; School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Queensland, Australia.; Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Waespy M; Centre for Biomolecular Interactions Bremen, Department of Biology and Chemistry, University of Bremen, Bremen, Germany.
Kelm S; Centre for Biomolecular Interactions Bremen, Department of Biology and Chemistry, University of Bremen, Bremen, Germany.
Anoopkumar-Dukie S; School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Queensland, Australia.; Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Haselhorst T; Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.; Pokaż więcej
Źródło:: International reviews of immunology [Int Rev Immunol] 2023; Vol. 42 (2), pp. 113-138. Date of Electronic Publication: 2021 Sep 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Sialic Acid Binding Ig-like Lectin 1*/metabolism
Communicable Diseases*
Animals ; Humans ; Sialic Acid Binding Immunoglobulin-like Lectins/metabolism ; Sialic Acids ; Immunoglobulins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Psychiatric symptoms in Salla disease.
Autorzy:: Aulanko I; PEDEGO Research Unit, University of Oulu, Oulu, Finland. .; Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland. .; Doctoral Programme in Clinical Research, University of Helsinki, Helsinki, Finland. .; Department of Clinical Genetics, Oulu University Hospital, OYS, P.O. Box 23, 90029, Oulu, Finland. .
Rahikkala E; PEDEGO Research Unit, University of Oulu, Oulu, Finland.; Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.; Institute of Biomedicine, University of Turku, Turku, Finland.; Department of Clinical Genetics, Oulu University Hospital, OYS, P.O. Box 23, 90029, Oulu, Finland.
Moilanen J; PEDEGO Research Unit, University of Oulu, Oulu, Finland.; Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.; Department of Clinical Genetics, Oulu University Hospital, OYS, P.O. Box 23, 90029, Oulu, Finland.; Pokaż więcej
Źródło:: European child & adolescent psychiatry [Eur Child Adolesc Psychiatry] 2023 Oct; Vol. 32 (10), pp. 2043-2047. Date of Electronic Publication: 2022 Jul 07.
Typ publikacji:: Review; Journal Article
MeSH Terms:: Sialic Acid Storage Disease*/drug therapy
Sialic Acid Storage Disease*/genetics
Mental Disorders*/diagnosis
Mental Disorders*/epidemiology
Mental Disorders*/drug therapy
Psychotic Disorders*/diagnosis
Psychotic Disorders*/epidemiology
Psychotic Disorders*/drug therapy
Antipsychotic Agents*/therapeutic use
Adolescent ; Humans ; Phenotype

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy.
Autorzy:: Yu Y; Department of General Surgery of Ruijin Hospital, Shanghai Institute of Digestive Surgery, and Shanghai Key Laboratory for Gastric Neoplasms, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Peng W; Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, China.; Pokaż więcej
Źródło:: Cancer biology & medicine [Cancer Biol Med] 2023 May 03; Vol. 20 (5).
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Sialic Acid Binding Immunoglobulin-like Lectins*
Neoplasms*/drug therapy
Humans ; Immunotherapy ; Antibodies, Monoclonal/therapeutic use ; Polysaccharides

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: A pan-cancer blueprint of genomics alterations and transcriptional regulation of Siglecs, and implications in prognosis and immunotherapy responsiveness.
Autorzy:: Mei S; Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, MOE Key Laboratory of Major Diseases in Children; Rare Disease Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.; Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Huang Y; Beijing ClouDNA Technology Co., Ltd., Beijing, China.
Zhao Y; Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China.
Zhang X; Beijing ClouDNA Technology Co., Ltd., Beijing, China.
Zhang P; Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, MOE Key Laboratory of Major Diseases in Children; Rare Disease Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.; Division of Immunotherapy, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Pokaż więcej
Źródło:: Clinical and translational medicine [Clin Transl Med] 2023 May; Vol. 13 (5), pp. e1262.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Sialic Acid Binding Immunoglobulin-like Lectins*
Neoplasms*/genetics
Neoplasms*/therapy
Humans ; Prognosis ; Genomics ; Immunotherapy

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions.
Autorzy:: Boelaars K; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
Rodriguez E; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
Huinen ZR; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
Liu C; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Amsterdam UMC location Vrije Universiteit Amsterdam, Pulmonary Medicine, De Boelelaan, 1117, Amsterdam, the Netherlands.
Wang D; Leiden University Medical Center, Center for Proteomics and Metabolomics, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
Springer BO; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
Olesek K; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
Goossens-Kruijssen L; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
van Ee T; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
Lindijer D; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
Tak W; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
de Haas A; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
Wehry L; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
Nugteren-Boogaard JP; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
Mikula A; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
de Winde CM; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
Mebius RE; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
Tuveson DA; Laboratory, Cold Spring Harbor, New York, USA.
Giovannetti E; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam UMC location Vrije Universiteit Amsterdam, Medical Oncology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Pharmacology Lab, AIRC Start-Up Unit, Fondazione Pisana per la Scienza, Pisa, Italy.
Bijlsma MF; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam UMC, location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands.
Wuhrer M; Leiden University Medical Center, Center for Proteomics and Metabolomics, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
van Vliet SJ; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
van Kooyk Y; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, De Boelelaan, 1117, Amsterdam, Netherlands. .; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands. .; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands. .; Pokaż więcej
Źródło:: Communications biology [Commun Biol] 2024 Apr 09; Vol. 7 (1), pp. 430. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Journal Article
MeSH Terms:: Cancer-Associated Fibroblasts*/metabolism
Pancreatic Neoplasms*/pathology
Carcinoma, Pancreatic Ductal*/metabolism
Humans ; N-Acetylneuraminic Acid/metabolism ; Sialic Acid Binding Immunoglobulin-like Lectins/metabolism ; Macrophages/metabolism ; Polysaccharides/metabolism ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Relationships of SIGLEC family-related lncRNAs with clinical prognosis and tumor immune microenvironment in ovarian cancer.
Autorzy:: Jin X; Department of Gynaecology, Shengjing Hospital of China Medical University, Shenyang, China.
Chen Y; Department of Ultrasound, Xiaoshan Traditional Chinese Medical Hospital, Hangzhou, China.
Hu Q; Department of Gynaecology, Shengjing Hospital of China Medical University, Shenyang, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 31; Vol. 14 (1), pp. 7593. Date of Electronic Publication: 2024 Mar 31.
Typ publikacji:: Journal Article
MeSH Terms:: RNA, Long Noncoding*/genetics
Ovarian Neoplasms*/genetics
Humans ; Female ; Sialic Acid Binding Immunoglobulin-like Lectins ; Prognosis ; Antigen Presentation ; Tumor Microenvironment/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Identification of BACH1-IT2-miR-4786-Siglec-15 immune suppressive axis in bladder cancer.
Autorzy:: Li X; Department of Urology, The Second Affiliated Hospital of The Chinese University of HongKong/Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, Guangdong, China. .
Liang Z; Department of Urology, The Second Affiliated Hospital of The Chinese University of HongKong/Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, Guangdong, China.
Pan J; Department of Urology, The Second Affiliated Hospital of The Chinese University of HongKong/Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, Guangdong, China.
Zhang M; Warshel Institute for Computational Biology, The Chinese University of Hong Kong, Longgang District, Shenzhen, 518172, Guangdong, China.
Liu J; Department of Urology, The Second Affiliated Hospital of The Chinese University of HongKong/Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, Guangdong, China.
Hu R; Department of Urology, The Second Affiliated Hospital of The Chinese University of HongKong/Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, Guangdong, China.
Liao C; Department of Urology, The Second Affiliated Hospital of The Chinese University of HongKong/Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, Guangdong, China.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 11; Vol. 24 (1), pp. 328. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:: Journal Article
MeSH Terms:: MicroRNAs*/genetics
MicroRNAs*/metabolism
Urinary Bladder Neoplasms*/genetics
Humans ; Sialic Acid Binding Immunoglobulin-like Lectins/metabolism ; Tumor Microenvironment/genetics ; Basic-Leucine Zipper Transcription Factors/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.
Autorzy:: Narayan R; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Center for Leukemia, Boston, Massachusetts, USA.
Piérola AA; Clínica Universidad de Navarra Pamplona, Pamplona, Spain.
Donnellan WB; Hematology/Medical Oncology, Tennessee Oncology/Sarah Cannon Research Institute, Nashville, Tennessee, USA.
Yordi AM; Experimental Hematology Unit, Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain.
Abdul-Hay M; Division of Hematology & Medical Oncology, Perlmutter Cancer Center at NYU Langone Health, New York, New York, USA.
Platzbecker U; Clinic and Polyclinic for Hematology, Cell Therapy and Hemostaseology, University Hospital in Leipzig, Leipzig, Germany.
Subklewe M; Laboratory for Translational Cancer Immunology, Ludwig-Maximilians-Universität München, Munich, Germany.
Kadia TM; Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, Texas, USA.
Alonso-Domínguez JM; Hematología y Hemoterapia, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
McCloskey J; Division of Leukemia, Hackensack University Medical Center, Hackensack, New Jersey, USA.
Bradford K; Janssen Research & Development LLC, Spring House, Pennsylvania, USA.
Curtis M; Janssen Research & Development LLC, Research Triangle Park, North Carolina, USA.
Daskalakis N; Janssen Research & Development LLC, Spring House, Pennsylvania, USA.
Guttke C; Janssen Research & Development LLC, Spring House, Pennsylvania, USA.
Safer K; Janssen Research & Development LLC, Spring House, Pennsylvania, USA.
Hiebert B; Janssen Pharmaceutica NV, Research & Development, Beerse, Belgium.
Murphy J; Janssen Research & Development LLC, High Wycombe, UK.
Li X; Janssen Research & Development LLC, Spring House, Pennsylvania, USA.
Duchin K; Janssen Research & Development LLC, Spring House, Pennsylvania, USA.
Esteban D; Grupo de Investigación, Hospital Clinico de Barcelona, Barcelona, Spain.; Pokaż więcej
Źródło:: Clinical and translational science [Clin Transl Sci] 2024 Mar; Vol. 17 (3), pp. e13742.
Typ publikacji:: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents*/therapeutic use
Leukemia, Myeloid, Acute*/drug therapy
Myelodysplastic Syndromes*/drug therapy
Humans ; Sialic Acid Binding Ig-like Lectin 3/immunology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Alzheimer's Disease-Associated Alternative Splicing of CD33 Is Regulated by the HNRNPA Family Proteins.
Autorzy:: Komuro R; Department of Bioinformatics and Molecular Neuropathology, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi 204-8588, Japan.; Department of RNA Pathobiology and Therapeutics, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi 204-8588, Japan.; Department of Molecular and Cellular Biochemistry, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi 204-8588, Japan.
Honda Y; Department of Bioinformatics and Molecular Neuropathology, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi 204-8588, Japan.
Yanaizu M; Department of Bioinformatics and Molecular Neuropathology, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi 204-8588, Japan.; Department of RNA Pathobiology and Therapeutics, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi 204-8588, Japan.
Nagahama M; Department of Molecular and Cellular Biochemistry, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi 204-8588, Japan.
Kino Y; Department of Bioinformatics and Molecular Neuropathology, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi 204-8588, Japan.; Department of RNA Pathobiology and Therapeutics, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi 204-8588, Japan.; Pokaż więcej
Źródło:: Cells [Cells] 2023 Feb 13; Vol. 12 (4). Date of Electronic Publication: 2023 Feb 13.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Alternative Splicing*
Alzheimer Disease*/metabolism
Sialic Acid Binding Ig-like Lectin 3*/metabolism
Animals ; Humans ; Mice ; Exons ; Protein Isoforms/metabolism ; RNA Splicing

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity.
Autorzy:: Bouti P; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Blans C; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Klein BJAM; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Shome D; LUMICKS, Paalbergweg 3, 1105 AG Amsterdam, The Netherlands.
Nadafi R; LUMICKS, Paalbergweg 3, 1105 AG Amsterdam, The Netherlands.
Van Houdt M; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Schornagel K; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Verkuijlen PJJH; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Roos V; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Reijmers RM; LUMICKS, Paalbergweg 3, 1105 AG Amsterdam, The Netherlands.
Van Bruggen R; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Kuijpers TW; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.; Department of Pediatric Immunology and Infectious Diseases, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Matlung HL; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 05; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 05.
Typ publikacji:: Journal Article
MeSH Terms:: Neutrophils*/metabolism
Neoplasms*/drug therapy
Humans ; N-Acetylneuraminic Acid ; Macrophage-1 Antigen ; Sialic Acid Binding Immunoglobulin-like Lectins/metabolism ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Genetic modifications designed for xenotransplantation attenuate sialoadhesin-dependent binding of human erythrocytes to porcine macrophages.
Autorzy:: Petitpas K; MGH, Center for Transplantation Sciences, Boston, Massachusetts, USA.
Habibabady Z; MGH, Center for Transplantation Sciences, Boston, Massachusetts, USA.
Ritchie V; MGH, Center for Transplantation Sciences, Boston, Massachusetts, USA.
Connolly MR; MGH, Center for Transplantation Sciences, Boston, Massachusetts, USA.
Burdorf L; MGH, Center for Transplantation Sciences, Boston, Massachusetts, USA.
Qin W; eGenesis Inc., Cambridge, Massachusetts, USA.
Kan Y; eGenesis Inc., Cambridge, Massachusetts, USA.
Layer JV; eGenesis Inc., Cambridge, Massachusetts, USA.
Crabtree JN; eGenesis Inc., Cambridge, Massachusetts, USA.
Youd ME; eGenesis Inc., Cambridge, Massachusetts, USA.
Westlin WF; eGenesis Inc., Cambridge, Massachusetts, USA.
Magnani DM; MassBiologics of UMMS, Boston, Massachusetts, USA.
Pierson RN 3rd; MGH, Center for Transplantation Sciences, Boston, Massachusetts, USA.
Azimzadeh AM; MGH, Center for Transplantation Sciences, Boston, Massachusetts, USA.; Pokaż więcej
Źródło:: Xenotransplantation [Xenotransplantation] 2022 Nov; Vol. 29 (6), pp. e12780. Date of Electronic Publication: 2022 Sep 20.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Sialic Acid Binding Ig-like Lectin 1*/genetics
N-Acetylneuraminic Acid*/metabolism
Humans ; Swine ; Animals ; Transplantation, Heterologous/methods ; Macrophages ; Erythrocytes/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Identification of therapeutic targets and prognostic biomarkers in the Siglec family of genes in tumor immune microenvironment of sarcoma.
Autorzy:: Qi L; Department of Orthopedic Oncology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.; Department of Orthopedic Research Center, The Third Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.; Experimental Center for Teaching of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Jiang K; National Demonstration Center for Experimental Basic Medical Education, Capital Medical University, Beijing, People's Republic of China.
Zhao FF; Department of Orthopedics, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Ren P; Experimental Center for Teaching of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Wang L; Department of Orthopedic Oncology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China. .; Department of Orthopedic Research Center, The Third Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Jan 05; Vol. 14 (1), pp. 577. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:: Journal Article
MeSH Terms:: Sarcoma*/genetics
Soft Tissue Neoplasms*
Humans ; Sialic Acid Binding Immunoglobulin-like Lectins/genetics ; Prognosis ; Biomarkers ; Tumor Microenvironment/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: TNFα induces Caspase-3 activity in hematopoietic progenitor cells CD34+, CD33+, and CD41 + of myelodysplastic syndromes.
Autorzy:: Iriani A; Department of Clinical Pathology, Faculty of Medicine, Yarsi University - Yarsi Hospital, Jl. Letjen Suprapto Kav 13, Cempaka Putih, Jakarta, 10510, Indonesia. .
Rachman A; Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Setiabudy RD; Department of Clinical Pathology, University of Indonesia, Jakarta, Indonesia.
Kresno SB; Department of Clinical Pathology, University of Indonesia, Jakarta, Indonesia.
Sudoyo AW; Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Arief M; Department of Clinical Pathology, Hasanuddin University, Makasar, Indonesia.
Harahap AR; Department of Clinical Pathology, University of Indonesia, Jakarta, Indonesia.
Fatina MK; Faculty of Medicine, Andalas University, Padang, Indonesia.; Pokaż więcej
Źródło:: BMC molecular and cell biology [BMC Mol Cell Biol] 2023 Nov 21; Vol. 24 (1), pp. 33. Date of Electronic Publication: 2023 Nov 21.
Typ publikacji:: Journal Article
MeSH Terms:: Tumor Necrosis Factor-alpha*
Myelodysplastic Syndromes*
Humans ; Caspase 3 ; Hematopoietic Stem Cells ; Antigens, CD34 ; Cell Adhesion Molecules ; Sialic Acid Binding Ig-like Lectin 3

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.
Autorzy:: Castaño-Bonilla T; Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Instituto de Investigación Sanitaria (IIS-FJD), Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Barragán E; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Sargas C; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Sanz A; Hematology Department, Hospital HM Sanchinarro, Madrid, Spain.
Algarra L; Hematology Department, Hospital General Universitario de Albacete, Albacete, Spain.
Herrera-Puente P; Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
García-Boyero R; Hematology Department, Hospital General de Castellón, Castellón de la Plana, Spain.
Barrios M; Hematology Department, Hospital Regional Universitario de Málaga, Málaga, Spain.
Martinez-Cuadron D; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Rodriguez-Veiga R; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Boluda B; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Gil C; Hematology Department, Hospital General Universitario de Alicante, Alicante, Spain.
Serrano-López J; Hematology Department, Hospital Universitario Reina Sofía, Córdoba, Spain.
Martínez-López J; Hematology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.
Sayas-Lloris MJ; Hematology Department, Hospital Universitario Doctor Peset, Valencia, Spain.
Olave MT; Hematology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
Riaza-Grau R; Hematology Department, Hospital Universitario Severo Ochoa, Madrid, Spain.
Castillo TB; Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Larrayoz MJ; Molecular Biology Department, Cimalab Diagnosis, Clínica Universitaria de Navarra, Pamplona, Spain.
Amigo R; Biobanco La Fe, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Jiménez-Velasco A; Hematology Department, Hospital Regional Universitario de Málaga, Málaga, Spain.
Sánchez J; Hematology Department, Hospital Universitario Reina Sofía, Córdoba, Spain.
Ayala R; Hematology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.
Blas C; Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Instituto de Investigación Sanitaria (IIS-FJD), Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Lainez D; Instituto de Investigación Sanitaria (IIS-FJD), Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Serrano-López J; Instituto de Investigación Sanitaria (IIS-FJD), Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Sanz MA; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Alonso-Domínguez JM; Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Instituto de Investigación Sanitaria (IIS-FJD), Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Montesinos P; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.; Pokaż więcej
Źródło:: Disease markers [Dis Markers] 2022 Aug 23; Vol. 2022, pp. 3132941. Date of Electronic Publication: 2022 Aug 23 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Aminoglycosides*/therapeutic use
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Sialic Acid Binding Ig-like Lectin 3*/genetics
Antibodies, Monoclonal, Humanized/genetics ; Gemtuzumab/therapeutic use ; Humans ; Polymorphism, Single Nucleotide

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Ablation of Siglec-E augments brain inflammation and ischemic injury.
Autorzy:: Li L; Department of Pharmaceutical Sciences, Drug Discovery Center, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA.
Chen Y; Department of Pharmaceutical Sciences, Drug Discovery Center, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA.
Sluter MN; Department of Pharmaceutical Sciences, Drug Discovery Center, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA.
Hou R; Department of Pharmaceutical Sciences, Drug Discovery Center, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA.
Hao J; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA.
Wu Y; Children's Foundation Research Institute at Le Bonheur Children's Hospital, Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Chen GY; Children's Foundation Research Institute at Le Bonheur Children's Hospital, Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Yu Y; Department of Pharmaceutical Sciences, Drug Discovery Center, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA.
Jiang J; Department of Pharmaceutical Sciences, Drug Discovery Center, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA. .; Pokaż więcej
Źródło:: Journal of neuroinflammation [J Neuroinflammation] 2022 Jul 20; Vol. 19 (1), pp. 191. Date of Electronic Publication: 2022 Jul 20.
Typ publikacji:: Journal Article
MeSH Terms:: Encephalitis*/pathology
Sialic Acid Binding Immunoglobulin-like Lectins*/metabolism
Animals ; Infarction, Middle Cerebral Artery/pathology ; Lipopolysaccharides/pharmacology ; Mice ; Microglia/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.
Autorzy:: Shi H; Soochow University Medical College, Suzhou, Jiangsu, People's Republic of China.
Gao L; Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu, People's Republic of China.
Zhang W; Department of Gastroenterology, Xiangcheng People's Hospital, Suzhou, 215131, People's Republic of China. .
Jiang M; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, People's Republic of China. .; Pokaż więcej
Źródło:: BMC bioinformatics [BMC Bioinformatics] 2022 Jul 19; Vol. 23 (1), pp. 284. Date of Electronic Publication: 2022 Jul 19.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/metabolism
Sialic Acid Binding Immunoglobulin-like Lectins*/genetics
Sialic Acid Binding Immunoglobulin-like Lectins*/metabolism
Aging/genetics ; Antigens, CD/metabolism ; Cohort Studies ; Humans ; Lectins/metabolism ; Prognosis ; ROC Curve ; Receptors, Cell Surface/genetics ; Receptors, Cell Surface/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Siglecs in Brain Function and Neurological Disorders.
Autorzy:: Siddiqui SS; Department of Biotechnology, American University of Ras Al Khaimah (AURAK), Ras Al Khaimah 10021, UAE. .
Matar R; Department of Biotechnology, American University of Ras Al Khaimah (AURAK), Ras Al Khaimah 10021, UAE. .
Merheb M; Department of Biotechnology, American University of Ras Al Khaimah (AURAK), Ras Al Khaimah 10021, UAE. .
Hodeify R; Department of Biotechnology, American University of Ras Al Khaimah (AURAK), Ras Al Khaimah 10021, UAE. .
Vazhappilly CG; Department of Biotechnology, American University of Ras Al Khaimah (AURAK), Ras Al Khaimah 10021, UAE. .
Marton J; Department of Biotechnology, American University of Ras Al Khaimah (AURAK), Ras Al Khaimah 10021, UAE. .
Shamsuddin SA; Department of Biotechnology, American University of Ras Al Khaimah (AURAK), Ras Al Khaimah 10021, UAE. .
Al Zouabi H; Department of Biotechnology, American University of Ras Al Khaimah (AURAK), Ras Al Khaimah 10021, UAE. .; Pokaż więcej
Źródło:: Cells [Cells] 2019 Sep 22; Vol. 8 (10). Date of Electronic Publication: 2019 Sep 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Brain/*physiology
Nervous System Diseases/*genetics
Nervous System Diseases/*immunology
Sialic Acid Binding Immunoglobulin-like Lectins/*physiology
Animals ; Antigens, CD/metabolism ; Antigens, CD/physiology ; Humans ; Mice ; Myelin-Associated Glycoprotein/physiology ; N-Acetylneuraminic Acid/metabolism ; Nervous System Diseases/physiopathology ; Sialic Acid Binding Ig-like Lectin 2/physiology ; Sialic Acid Binding Ig-like Lectin 3/physiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma.
Autorzy:: Liu T; Stem Cell Research Center, Shantou University Medical College, Shantou, 515041, Guangdong Province, China.
Dai X; Stem Cell Research Center, Shantou University Medical College, Shantou, 515041, Guangdong Province, China.
Xu Y; Stem Cell Research Center, Shantou University Medical College, Shantou, 515041, Guangdong Province, China.; Cancer Hospital, Shantou University Medical College, Shantou, 515041, Guangdong Province, China.
Guan T; Guangdong Procapzoom Biosciences, Inc., Shantou, 515041, Guangdong Province, China.
Hong L; Department of Pathology, The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong Province, China.
Zaib T; Stem Cell Research Center, Shantou University Medical College, Shantou, 515041, Guangdong Province, China.
Zhou Q; Stem Cell Research Center, Shantou University Medical College, Shantou, 515041, Guangdong Province, China.
Cheng K; Stem Cell Research Center, Shantou University Medical College, Shantou, 515041, Guangdong Province, China.
Zhou X; Stem Cell Research Center, Shantou University Medical College, Shantou, 515041, Guangdong Province, China.
Ma C; Stem Cell Research Center, Shantou University Medical College, Shantou, 515041, Guangdong Province, China. .; Cancer Hospital, Shantou University Medical College, Shantou, 515041, Guangdong Province, China. .
Sun P; Stem Cell Research Center, Shantou University Medical College, Shantou, 515041, Guangdong Province, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2023 Oct 10; Vol. 21 (1), pp. 710. Date of Electronic Publication: 2023 Oct 10.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Esophageal Squamous Cell Carcinoma*/therapy
Esophageal Neoplasms*/genetics
Carcinoma, Squamous Cell*/pathology
Hematologic Neoplasms*
Humans ; Biomarkers, Tumor/genetics ; Killer Cells, Natural ; Antigens, Surface/metabolism ; Cell- and Tissue-Based Therapy ; Cell Line, Tumor ; Tumor Microenvironment ; Sialic Acid Binding Ig-like Lectin 2/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: CD19/CD22 dual-targeting chimeric antigen receptor T-cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B-cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein-Barr virus viremia after transplantation.
Autorzy:: Li S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Ge J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhou S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Zhu W; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Han Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Chen S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Xue S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Wang Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Qiu H; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Wu X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.
Wu D; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China.; Pokaż więcej
Źródło:: Clinical and translational medicine [Clin Transl Med] 2023 Oct; Vol. 13 (10), pp. e1459.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Receptors, Chimeric Antigen*/genetics
Epstein-Barr Virus Infections*
Hematopoietic Stem Cell Transplantation*/adverse effects
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*
Humans ; Cytomegalovirus ; Herpesvirus 4, Human ; Viremia ; Sialic Acid Binding Ig-like Lectin 2

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""SIALIC-ACID"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język